Attitudes of patients with cutaneous melanoma toward prognostic testing using the 31‐gene expression profile test

Most newly diagnosed CM patients desired prognostic information about their tumors. Patients who received 31-GEP testing felt it was useful and did not regret their decision to undergo 31-GEP testing.